Naproxen Accord (Naproxen)

Naproxen works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By reducing prostaglandin production, naproxen diminishes the inflammatory response, decreases pain signaling, and helps lower elevated body temperature.

The appropriate dose of Naproxen Accord is determined by the prescribing healthcare professional based on the patient’s condition, severity, age, and renal or hepatic function. Dosage regimens can vary, and patients should follow the prescriber’s instructions without altering the amount or frequency on their own.

Naproxen is generally classified as a category that should be avoided during the third trimester of pregnancy because of potential fetal cardiovascular effects. Use during the first two trimesters should only occur if the benefit outweighs the risk and under medical supervision. Naproxen passes into breast milk, so nursing mothers should consult their physician before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Naproxen has a longer half‑life than many NSAIDs such as ibuprofen, allowing for twice‑daily dosing in many cases. It provides comparable analgesic and anti‑inflammatory efficacy but may carry a slightly higher risk of gastrointestinal irritation. Compared with selective COX‑2 inhibitors, naproxen offers broader COX inhibition but lacks the reduced GI‑bleed profile of COX‑2‑selective agents.

Naproxen Accord should be stored at room temperature, below 25 °C (77 °F). Keep the tablets in the original packaging to protect them from moisture and light. Do not store in areas with high humidity or extreme temperatures, as this could affect product stability.

Naproxen Accord is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food or milk may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not split, crush, or chew it unless specifically instructed by a healthcare professional.

The most serious risks include gastrointestinal bleeding or ulcer perforation, especially in patients with a history of ulcers or concurrent anticoagulant use. Cardiovascular events such as heart attack or stroke may occur, particularly with long‑term use or in patients with existing heart disease. Renal impairment and severe skin reactions are also rare but critical adverse events that require immediate medical attention.

Naproxen Accord should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulcers or bleeding, patients with severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated during the third trimester of pregnancy. Physicians should evaluate each patient’s medical history before prescribing.